Cardiac Deaths Remain Elevated Since 2020
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 4, 2025 -- Cardiac deaths increased substantially starting in 2020, according to a research letter published online May 30 in JAMA Network Open.
Jason H. Wasfy, M.D., from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues described monthly and annual population-based cardiac mortality rates using state death certificate data and reported actual and estimated expected monthly cardiac death rates during and after the COVID-19 pandemic. The analysis included death certificate data for 127,746 Massachusetts decedents (January 2014 to July 2024). As of mid-2024, some monthly rates remained elevated.
The researchers found that annual observed cardiac mortality exceeded expected from 2020 to 2023: 16 percent higher in 2020, 17 percent higher in 2021 and 2022, and 6 percent higher in 2023. Cardiac mortality rates exceeded expected for deaths both at home (between 2020 and 2022) and for deaths in hospitals (between 2020 and 2023).
“Lots of reports have shown that there have been fewer heart attacks in hospitals since 2020—but something seems to be missing from that data,” Wasfy said in a statement. “We now show that if you account for deaths at home, cardiac deaths are going up and have stayed up for years. Today there are a lot more people having cardiac deaths at home, which also raises the concern that people with heart disease haven’t been getting the care they need since the pandemic."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-05 06:00
Read more

- Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea
- Tiny Baby’s Life-Threatening Wound Healed With Fish Skin
- Military Service Might Protect Against Depression
- Johnson & Johnson Unveils First-in-Human Results for Pasritamig, Showing Early Anti-Tumor Activity in Prostate Cancer
- Mailed Self-Collection Kits Increase Rates of Cervical Cancer Screening
- Miley Cyrus Reveals Rare Condition That Shapes Her Signature Voice
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions